The cost-effectiveness and cost-utility analysis of the use of enoxaparin compared with heparin for venous thromboembolism prophylaxis in medical inpatients in Iran

IF 2.5 4区医学 Q3 PHARMACOLOGY & PHARMACY

DARU Journal of Pharmaceutical Sciences Pub Date : 2019-07-31 DOI:10.1007/s40199-019-00292-1

Mohammadreza Amirsadri, Sarah Mousavi, Ali Karimipour

引用次数: 8

查看原文本刊更多论文

伊诺肝素与肝素在伊朗医疗住院患者静脉血栓栓塞预防中的成本效益和成本效用分析

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

DARU Journal of Pharmaceutical Sciences PHARMACOLOGY & PHARMACY-

自引率

0.00%

发文量

期刊介绍： DARU Journal of Pharmaceutical Sciences is a peer-reviewed journal published on behalf of Tehran University of Medical Sciences. The journal encompasses all fields of the pharmaceutical sciences and presents timely research on all areas of drug conception, design, manufacture, classification and assessment. The term DARU is derived from the Persian name meaning drug or medicine. This journal is a unique platform to improve the knowledge of researchers and scientists by publishing novel articles including basic and clinical investigations from members of the global scientific community in the forms of original articles, systematic or narrative reviews, meta-analyses, letters, and short communications.